Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-07-2023 | Phlebothrombosis | Case report

Baricitinib/tofacitinib

Pulmonary embolism, deep vein thrombosis and digestive manifestations: 6 case reports

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Philippoteaux C, et al. Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings. Journal of Clinical Medicine 12: No. 1, 2023. Available from: URL: http://doi.org/10.3390/jcm12010207 Philippoteaux C, et al. Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings. Journal of Clinical Medicine 12: No. 1, 2023. Available from: URL: http://​doi.​org/​10.​3390/​jcm12010207
Metadata
Title
Baricitinib/tofacitinib
Pulmonary embolism, deep vein thrombosis and digestive manifestations: 6 case reports
Publication date
01-07-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-43079-6

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Valproic-acid

Case report

Multiple drug

Case report

Multiple drugs

Case report

Antineoplastics